Are Peptides Legal? FDA Status, Prescriptions and Gray Areas

Four Cases

Are Peptides Legal in the US? Four Cases, Four Answers

Some peptides are legal in the US and some are not. The answer turns on the peptide and on the route it takes to the patient. A peptide is a short chain of amino acids, and insulin is one. Federal law does not regulate peptides as a class. It regulates drugs, and it looks at what a product is, who made it and what it is intended for.

Protocol Health offers BPC-157, TB-500, ipamorelin, CJC-1295, sermorelin, GHK-Cu, Selank, Semax and tesamorelin through physician-supervised care, and it prescribes GLP-1 medications. The clinic also prescribes testosterone therapy, anastrozole alongside it, and enclomiphene, none of which is a peptide. That is a commercial interest in the first three rows, and it is why this article quotes the FDA's own wording instead of paraphrasing it. Nothing here is legal advice. A healthcare attorney can answer a question about your own situation.

FDA-Approved

Are Any Peptides FDA-Approved?

Yes. Some peptides are FDA-approved drugs, and each approval covers named uses only. Tirzepatide is approved as Mounjaro for blood sugar control in adults with type 2 diabetes and as Zepbound for chronic weight management. Semaglutide is the active ingredient in Ozempic and Wegovy. Tesamorelin (Egrifta) is approved to reduce excess abdominal fat in HIV-infected adults with lipodystrophy, and its label states that it is not indicated for weight loss management.

Approval is not a statement that a drug is free of risk. The FDA's Zepbound announcement notes that tirzepatide causes thyroid C-cell tumors in rats and should not be used by patients with a personal or family history of medullary thyroid cancer or with Multiple Endocrine Neoplasia syndrome type 2.

Most other marketed peptides are not FDA-approved. Approval is granted to a specific product for a specific use after a sponsor submits evidence of safety and effectiveness. BPC-157, TB-500, CJC-1295 and ipamorelin have not been through that process, so they have never been FDA-approved for any use. Prescribing them is not "off-label" use. Off-label describes an approved drug prescribed for a different purpose, and these four have no approved purpose to depart from.

Compounded

Compounded Peptides: Lawful Under Section 503A, Not FDA-Approved

Compounded peptides are legal to prescribe and dispense when a state-licensed pharmacy or physician prepares them under Section 503A of the Federal Food, Drug, and Cosmetic Act and meets its conditions. They are not FDA-approved. The FDA's compounding Q&A says: "Compounded drugs are not FDA-approved. This means that FDA does not verify the safety, effectiveness or quality of compounded drugs before they are marketed."

Section 503A limits which ingredients a compounder may start from. The FDA's page on 503A bulk drug substances gives three routes. A bulk substance must:

• comply with a United States Pharmacopeia or National Formulary monograph, if one exists;
• be a component of an FDA-approved drug product, if no monograph exists; or
• appear on the FDA's 503A bulks list, if neither of the first two applies.

Sermorelin has an approval history the four never-approved peptides lack. Sermorelin acetate was the active ingredient in Geref, approved in 1990 and 1997. The manufacturer discontinued Geref in 2008, and a 2013 Federal Register notice records the FDA's determination that Geref was "not withdrawn for reasons of safety or effectiveness." The sermorelin prescribed now is compounded, so it is not an FDA-approved product. The guide to what sermorelin is covers its evidence and side effects.

Never Approved

BPC-157, TB-500, CJC-1295 and Ipamorelin: Where the FDA Lists Them

BPC-157, TB-500, CJC-1295 and ipamorelin have never been FDA-approved for any use, and none of them appears in Category 1 of the FDA's 503A interim policy in the category list updated May 14, 2026. The FDA's page on bulk drug substances that may present significant safety risks, current as of April 22, 2026, places them as follows.

The FDA describes the withdrawn group as substances "previously in category 2 of the interim policies" that "were withdrawn by the nominators." Category position matters because it sets the agency's enforcement posture. For Category 1, the FDA says it "does not intend to take action against a compounder" when the conditions in its guidance are met. For Category 2 and Category 3, the FDA says it "would consider taking action against a compounder" under its general enforcement policies. A withdrawn nomination leaves a substance outside Category 1, the only category that policy covers. A clinician's prescription does not change where a substance sits on the lists.

The lists are under review. On July 23, 2026, the FDA's Pharmacy Compounding Advisory Committee discussed BPC-157 and TB-500, with five other peptides across two days, for possible inclusion on the 503A bulks list. CJC-1295 and ipamorelin were not on the agenda. According to the Johns Hopkins Bloomberg School of Public Health, FDA staff opposed inclusion, and the committee voted to recommend six of the seven peptides. The FDA's briefing document for that meeting says the evaluation criteria "weigh against" placing BPC-157 on the 503A list. The FDA calls advisory committee recommendations non-binding, and the Johns Hopkins account notes that the decision now returns to the agency. This article does not predict what the FDA will decide.

Each peptide has its own evidence base, covered in the guides to what BPC-157 is and to CJC-1295 and ipamorelin.

Research Vials

Is It Illegal to Buy Peptides Online Labeled "Research Use Only"?

Selling an unapproved peptide for human use as a research chemical, with no prescription and no pharmacy, is illegal under federal law, whatever the label says. Writing about semaglutide, tirzepatide and other GLP-1 peptides, the FDA states that it "has warned companies that have illegally sold unapproved drugs" that are "falsely labeled 'for research purposes' or 'not for human consumption.'" The agency adds that these products "have been sold directly to consumers for human use with dosing instructions" and urges consumers not to buy them because they "are of unknown quality and may be harmful to their health."

The label does not protect the seller. In a December 2024 warning letter to a peptide website, the FDA wrote that despite labeling that marketed the products as "RESEARCH USE ONLY," evidence from the company's websites showed the products were "intended to be drugs for human use." The letter called them unapproved new drugs introduced into interstate commerce in violation of the Federal Food, Drug, and Cosmetic Act.

Is it illegal to sell peptides? For human use without approval or a lawful compounding pathway, the FDA says yes, and its warning letters go to sellers. Is it illegal to buy peptides, or to take them? The provisions cited in that letter address introducing an unapproved drug into interstate commerce. Whether a buyer has legal exposure depends on the facts and on state law, a question for an attorney. The comparison of pharmaceutical-grade and research-grade peptides explains what a buyer gives up without a pharmacy behind the vial.

DEA

Are Peptides a Controlled Substance?

Most peptides are not controlled substances. The DEA's alphabetical list of controlled substances, dated August 27, 2026, does not list semaglutide, tirzepatide, tesamorelin, sermorelin, BPC-157, CJC-1295, ipamorelin or TB-500. Testosterone, by comparison, is on that list in Schedule III.

Unscheduled does not mean unregulated. The approval and compounding rules in the Federal Food, Drug, and Cosmetic Act apply to a drug whether or not the DEA schedules it.

Human growth hormone is a separate case. Under 21 U.S.C. 333(e), knowingly distributing human growth hormone for any use in humans other than the treatment of a disease or other recognized medical condition, where that use has been authorized under the drug approval statute and is pursuant to a physician's order, is a federal offense punishable by up to five years in prison. The statute defines human growth hormone as somatrem, somatropin or an analogue of either.

Sports

Are Peptides Illegal in Sports? WADA and the NCAA

A peptide that is legal to prescribe can still be banned in sport. The World Anti-Doping Agency's 2026 Prohibited List names CJC-1295, sermorelin, tesamorelin and ipamorelin as growth hormone releasing factors, and TB-500 as a thymosin beta-4 derivative, under section S2. It names BPC-157 under section S0, non-approved substances. Both sections are prohibited at all times, in and out of competition.

Are peptides banned by the NCAA? The NCAA's banned substances list bans "peptide hormones, growth factors, related substances and mimetics" as a class. Its examples include BPC-157, TB-500, growth hormone and ibutamoren.

Athletes subject to testing should check with their governing body before starting any peptide. The guide to peptides for muscle growth covers what the human trials measured.

States

Are Peptides Legal in California, Florida and New York?

Peptides have the same FDA status in California, Florida, New York and every other state, because drug approval and the Section 503A compounding rules are federal.

States add a second layer by licensing the people involved. The FDA notes that "state boards of pharmacy have primary responsibility for the day-to-day oversight of state-licensed pharmacies that are not registered with FDA as outsourcing facilities." State boards write their own pharmacy regulations, so a pharmacy's obligations can differ by state even though the federal status of the peptide does not.

Two state-level checks apply anywhere: whether the prescriber holds a license in your state, and whether the pharmacy is licensed by a state board of pharmacy. The FDA's advice to patients is to "obtain a prescription from their doctor and fill the prescription at a state-licensed pharmacy." Protocol Health sees patients in person in Scarsdale, New York, and by telehealth in New York, New Jersey, Connecticut, Florida and California.

Prescriptions

Do You Need a Prescription for Peptides?

Yes, for the peptide drugs discussed in this article. Approved products such as Zepbound and Egrifta are prescription drugs. For compounded peptides, Section 503A requires a valid prescription order for an identified individual patient. A website that ships an injectable peptide with no prescription is outside both routes.

Collagen peptide powders are a different category: they are sold as dietary supplements and are not the subject of this article.

The FDA publishes warning signs for telehealth sellers of compounded GLP-1 drugs, and they apply to any peptide source. The agency's red flags include a company that:

• does not require a screening and prescription by a licensed doctor before providing medicine;
• claims that a compounded drug is the same as an FDA-approved drug;
• offers medicine at deep discounts or at prices that seem too good to be true.

Our Approach

Peptide Care at Protocol Health and the Bottom Line

Protocol Health is a physician-led practice in Scarsdale, New York. The Protocol Health peptide consultation starts with a medical history and baseline labs. A clinician reviews those labs and decides whether a peptide is appropriate. The FDA status described in this article applies to what we prescribe: compounded sermorelin is not an FDA-approved product, and BPC-157, TB-500, CJC-1295, ipamorelin, injectable GHK-Cu, Selank and Semax have never been FDA-approved for any use. Tesamorelin is FDA-approved only as Egrifta, for excess abdominal fat in HIV-associated lipodystrophy; other use is off-label, and a compounded tesamorelin is not FDA-approved. The peptide therapy guide explains how treatment works, and the peptide therapy page lists what the practice offers.

Are peptides legal? FDA-approved peptide drugs are legal with a prescription. Compounded peptides are lawful under Section 503A's conditions and are not FDA-approved. BPC-157, TB-500, CJC-1295 and ipamorelin have never been approved and sit outside the FDA's Category 1 compounding policy. Research-labeled vials sold for human use are unapproved drugs, and the FDA has told their sellers so. Every source linked in this article was checked on October 5, 2026. The FDA updates these lists, so read its pages for the current position.

FAQ

Frequently Asked Questions

Explore

Related at Protocol Health

• Peptide Therapy →
• Sermorelin →
• CJC-1295 + Ipamorelin →
• BPC-157 →